Dispensing packages containing novel cyclic progestogen-interrup

Special receptacle or package – For ampule – capsule – pellet – or granule – Single layer in edge-to-edge array

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424239, A61K 3724, A61J 100

Patent

active

039426416

ABSTRACT:
This invention relates to a method of fertility control by use of novel cyclic progestogen-interrupted estrogen oral contraceptive regimens. Considering the first day of menstrual flow as day one of a 28 day medication administration cycle, a combined formulation of estrogen and progestogen substances is administered on the 3rd, 4th, 5th or 6th day of the cycle and every second or third day thereafter through, and including, the 23rd, 24th, 25th, 26th, 27th or 28th day of the cycle, and a formulation having only a progestogen substance as the active component is administered on the 4th, 5th, 6th, or 7th day of the cycle and every day thereafter on which a combination formulation is not administered, through, and including, the 22nd, 23rd, 24th, 25th, 26th, 27th or 28th day of the cycle.
In a particular regimen, a combination of estrogen and progestogen is administered starting with the 5th day of the cycle and continuing every other day through the 25th day of the cycle, and starting with the 6th day of the cycle and continuing every other day through the 24th day of the cycle only progestogen is administered. The remaining seven days are dosage-free or the regimen is completed by use of placebos or other nonhormonal supplements.
Dispensing packages for holding unit dosage forms for oral ingestion of one unit dosage form daily in the appropriate sequence during a single cycle of medication administration are also described.

REFERENCES:
patent: 3409721 (1968-11-01), Applezweig
patent: 3591688 (1971-07-01), Jones et al.
patent: 3624203 (1971-11-01), Overbeck
patent: 3660574 (1972-05-01), Berman
patent: 3755573 (1973-08-01), Berman
Morris et al., Amer. J. Obstet. Gynec. Vol. 96 pp. 804-815 (1966).
Ball C.M.A.J. Vol. 105 : 240 (1971).
Rudel Pharmacology of Oral Contraceptives, Clin. Obst. & Gynecol. Vol. 11, pp. 632-644 (1968).
Pincus et al., Ann. N.Y. Acad. Sci. Vol. 71 : 677-690 (1958).
Tyler et al., Obstet. Gynecol. Vol. 18 : 363-367 (1961).
Pincus, The Control of Fertility, Acad. Press, p. 219 (1965).
Rudel et al., The Biology of Anti-Fertility Steroids, Acta Endocrinologica Suppl. 105 : 32-34 (1966).
Harter et al., New Engl. J. Med., Vol. 269, pp. 591-596 (1963).
Soyka, Adv. In Pediatrics, Vol. 19 : 47-70 (1972).
Rudel, Fed. Proc. 29 : 1228-1231 (1970).
Cox, J. Reprod. Fert. Suppl. 5 : 167-172 (1968).
Foss, J. Reprod. Fert. Suppl. 5 : 145-159 (1968).
Rudel et al. I.E.P.T. Sect. 48, Vol. 2 : 385-417 (1972).
Greenblatt, Fert. & Steril., Vol. 18 : 207-211 (1967).
Coutinho et al., J. Reprod. Fert., Vol. 16 : 137-139 (1968).
Lotvin et al. Obstet. Gynec., Vol. 35 : 933-936 (1970).
Claman, Amer. J. Obstet. Gynec., Vol. 107 : 461-464 (1970).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Dispensing packages containing novel cyclic progestogen-interrup does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dispensing packages containing novel cyclic progestogen-interrup, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dispensing packages containing novel cyclic progestogen-interrup will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-827239

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.